Ziprasidone Hydrochloride Capsule
Product Images NDC 68084-103

13 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ziprasidone Hydrochloride (NDC 68084-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp10309

Ahp10309
Ziprasidone Hydrochloride 20 mg oral capsule, bicolor with a purple top and white bottom. The capsule is imprinted with "APO ZIP" on the purple half and "20" on the white half. Size references are visible in millimeters for scale.*
FDA Label Image

Ahp10409

Ahp10409
Ziprasidone Hydrochloride 40 mg oral capsule, purple in color. One side of the capsule is printed with the text 'APO ZIP 40'. The capsule is shown next to a millimeter ruler for size reference, indicating typical capsule dimensions.*
FDA Label Image

Ahp10509

Ahp10509
White capsule imprinted with black text reading 'APO ZIP' on the top half and '60' on the bottom half, indicating Ziprasidone Hydrochloride 60 mg oral capsule. The capsule is shown against a gray background with metric rulers for size reference.*
FDA Label Image

Ahp10609

Ahp10609
Ziprasidone Hydrochloride 80 mg oral capsules are two-toned with a purple top and white bottom. The capsule imprint includes "APO ZIP" on the purple half and "80" on the white half. The capsule is shown against a ruler scale for size reference.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of Ziprasidone Hydrochloride, illustrating its molecular framework with rings, nitrogen, sulfur, chlorine atoms, and other bonds characteristic to this antipsychotic agent.*
FDA Label Image

20 mg Ziprasidone Capsules Carton (20 mg Ziprasidone Capsules Carton)

20 mg Ziprasidone Capsules Carton (20 mg Ziprasidone Capsules Carton)
Label for Ziprasidone Hydrochloride Capsules, USP 20 mg oral capsules by American Health Packaging. The label states NDC 68084-103-09 and package contains 80 capsules (8 bottles of 10). It includes storage instructions, dosing caution, and a QR code for patient information and prescribing details.*
FDA Label Image

20 mg Ziprasidone Capsule Blister (20 mg Blister)

20 mg Ziprasidone Capsule Blister (20 mg Blister)
Label panel for Ziprasidone Hydrochloride capsules, USP 20 mg strength. The label includes the drug name, dosage form as capsule, strength (20 mg), and identifies American Health Packaging as the labeler. Additional fields for lot number and expiration date are present but with placeholder text 'xxxxxx' and 'xxxxxx' respectively. The label features barcodes and a standardized code line.*
FDA Label Image

40 mg Ziprasidone Capsules Carton (40 mg Ziprasidone Capsules Carton)

40 mg Ziprasidone Capsules Carton (40 mg Ziprasidone Capsules Carton)
Label for Ziprasidone Capsules, USP 40 mg oral capsules by American Health Packaging. Packaging contains 80 capsules (8 x 10). Includes NDC 68084-104-09, barcodes, pharmacist dispensing instructions, storage conditions, and a QR code for patient and prescribing information.*
FDA Label Image

40 mg Ziprasidone Capsule Blister (40 mg Blister)

40 mg Ziprasidone Capsule Blister (40 mg Blister)
Label sheet featuring multiple labels for Ziprasidone Hydrochloride Capsules, USP 40 mg. Each label includes the product name, strength, and dosage form along with a barcode, lot number placeholder, expiration date placeholder, and the labeler information for American Health Packaging, Columbus, Ohio.*
FDA Label Image

60 mg Ziprasidone Capsules Carton (60 mg Ziprasidone Capsules Carton)

60 mg Ziprasidone Capsules Carton (60 mg Ziprasidone Capsules Carton)
Label for Ziprasidone Capsules USP, 60 mg strength, in an 80-capsule package (8 blister packs of 10 capsules each). The label includes the NDC number 68084-105-09 and is distributed by American Health Packaging, with the drug product from Apotex Corp. It notes the capsules contain ziprasidone hydrochloride equivalent to 60 mg ziprasidone and includes instructions for patient information and pharmacist dispensing guidance.*
FDA Label Image

60 mg Ziprasidone Capsule Blister (60 mg Blister)

60 mg Ziprasidone Capsule Blister (60 mg Blister)
Multiple identical labels of Ziprasidone Capsule USP 60 mg in a sheet format. Each label includes the product name, strength, dosage form, a barcode, lot number, expiry date, and the labeler American Health Packaging, Columbus, Ohio.*
FDA Label Image

80 mg Ziprasidone Capsules Carton (80 mg Ziprasidone Capsules Carton)

80 mg Ziprasidone Capsules Carton (80 mg Ziprasidone Capsules Carton)
Packaging label for Ziprasidone Capsules USP, 80 mg strength, containing 80 capsules (8 x 10) in oral capsule dosage form. The label shows the NDC 68084-106-09 and indicates the product is Rx only. It is distributed by American Health Packaging with a note instructing pharmacists to dispense patient information. The label also includes storage instructions, usage notes, and a QR code for patient information and prescribing information.*
FDA Label Image

80 mg Ziprasidone Capsule Blister (80 mg Blister)

80 mg Ziprasidone Capsule Blister (80 mg Blister)
Multiple identical labels for Ziprasidone Capsule, USP 80 mg by American Health Packaging. Each label includes the product name, dosage strength of 80 mg, a barcode, a placeholder for lot number and expiration date, and the manufacturer information, American Health Packaging, Columbus, Ohio.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.